Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05194358 · ClinicalTrials.gov registry record · Phase 1
Study of SIAN Nasal Spray in Healthy Adults
A Phase 1 study, sponsored by Emergent BioSolutions.
- Completed
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT05194358 is a Phase 1 study that has completed, run by Emergent BioSolutions. The registered enrollment target is 47 participants.
The verdict
NCT05194358, a Phase 1 study, has completed, sponsored by Emergent BioSolutions.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of Stabilized Isoamyl Nitrite (SIAN) nasal spray in healthy subjects.
Interventions
- DRUG Stabilized Isoamyl Nitrite (SIAN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2021-12-21 |
| Est. Completion | 2023-10-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05194358
The ClinicalTrials.gov registry entry for NCT05194358 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emergent BioSolutions, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stabilized Isoamyl Nitrite (SIAN) is the first listed.
NCT05194358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05194358 about?
NCT05194358 is a clinical study titled "Study of SIAN Nasal Spray in Healthy Adults". This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of Stabilized Isoamyl Nitrite (SIAN) nasal spray in healthy subjects.
What is the current status of trial NCT05194358?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2021-12-21. Estimated completion is 2023-10-13.
What interventions are being tested in trial NCT05194358?
The interventions under investigation include: Stabilized Isoamyl Nitrite (SIAN) (DRUG).
Who is sponsoring clinical trial NCT05194358?
This trial is sponsored by Emergent BioSolutions, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.